Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Search content at Johns Hopkins University
Home
Profiles
Research units
Research output
Peptide vaccine for colorectal cancer; an update
Shoichi Hazama
, Koji Yoshida
, Hirokazu Shinozaki
, Yuka Inoue
, Yoshinari Maeda
, Yoshitaro Shindo
, Nobuaki Suzuki
, Kiyoshi Yoshimura
, Shigefumi Yoshino
, Takuya Tsunoda
, Hiroyuki Furukawa
, Yusuke Nakamura
, Masaaki Oka
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Peptide vaccine for colorectal cancer; an update'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Colorectal Cancer
100%
Tumor Antigen
100%
Peptide Vaccine
100%
Chemotherapy
50%
Cytotoxic T Lymphocytes
50%
Immuno
50%
Epitope Peptide
50%
Immunological Response
25%
Oxaliplatin
25%
Anticancer Drugs
25%
CDNA Microarray
25%
Tumor Cells
25%
Vascular Endothelial Growth Factor
25%
Clinical Response
25%
5-fluorouracil (5-FU)
25%
RNF43
25%
Phase II Trial
25%
Antigen-specific
25%
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
25%
Phase I Study
25%
Antigen Expression
25%
Antigenic Epitope
25%
Dose-escalation Study
25%
Pharmacologic Effects
25%
Death Signals
25%
Tumor Cell Death
25%
Colorectal Cancer Patients
25%
Combined Therapy
25%
Chemoimmunotherapy
25%
New Tumor
25%
Tumor Cell Resistance
25%
Folinic Acid
25%
TOMM34
25%
Microarray Assay
25%
Common Diseases
25%
Tumor Escape Mechanisms
25%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Colorectal Carcinoma
100%
Tumor Antigen
100%
Peptide Vaccine
100%
Chemotherapy Regimens
75%
Epitope
50%
Immunoglobulin
50%
Peptide
50%
Complementary DNA
25%
Anticarcinogen
25%
Oxaliplatin
25%
Immunotherapy
25%
Folinic Acid
25%
Fluorouracil
25%
Phase II Trials
25%
Diseases
25%
Immunology and Microbiology
Tumor Antigen
100%
Peptide Vaccine
100%
Colorectal Carcinoma
100%
Tumor Cell
75%
Epitope
50%
Intravenous Immunoglobulin
50%
Cytotoxic T Cell
50%
Peptides
50%
Immunotherapy
25%
Tumor Escape
25%
Antigen Expression
25%
Cell Killing
25%
cDNA Microarray
25%